Innocan Pharma Corp (INNPD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | INNPD | ||||
| Company | Innocan Pharma Corp | ||||
| Price Information | |||||
| Exchange | OTC US | ||||
| Open | 12.5300 | ||||
| High | 13.3500 | ||||
| Low | 12.5300 | ||||
| Latest | 12.5300 | ||||
| Change | -0.3900 | ||||
| % Change | -3.02% | ||||
| Volume | 300 | ||||
| 20-Day Average Volume | 160 | ||||
| Previous Close | 12.9200 | ||||
| Industry | N/A | ||||
| Has Options | No | ||||
| Technicals | |||||
| 20-Day Moving Average | 9.5667 | ||||
| 20-Day Raw Stochastic | 86.75% | ||||
| 20-Day Relative Strength | 54.28 | ||||
| Weighted Alpha | N/A | ||||
| Today's Opinion | N/A | ||||
| Previous Opinion | N/A | ||||
| Last Month's Opinion | N/A | ||||
| Performance | |||||
| 5-Days | |||||
| %Chg | +67.74% since 09/17/25 | ||||
| Low | 10.4700 on 09/26/25 | ||||
| High | 13.6500 on 09/29/25 | ||||
| 1-Month | |||||
| %Chg | +24.37% since 08/15/25 | ||||
| Low | 7.4700 on 09/17/25 | ||||
| High | 13.6500 on 09/29/25 | ||||
| 3-Month | |||||
| %Chg | +140.96% since 06/20/25 | ||||
| Low | 7.4700 on 09/17/25 | ||||
| High | 13.6500 on 09/29/25 | ||||
| 6-Month | |||||
| %Chg | +46.04% since 03/20/25 | ||||
| Low | 5.2000 on 06/20/25 | ||||
| High | 13.6500 on 09/29/25 | ||||
| Key Statistics | |||||
| Market Capitalization, $K | N/A | ||||
| Shares Outstanding, K | N/A | ||||
| Annual Sales | 729,472,000 | ||||
| Annual Net Income | -5,067,000 | ||||
| Last Quarter Sales | 174,960,000 | ||||
| Last Quarter Net Income | -1,346,000 | ||||
| 60-Month Beta | N/A | ||||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | ||||
| Latest Earnings Date | N/A | ||||
| Most Recent Dividend | N/A | ||||
| Next Ex-Dividends Date | N/A | ||||
| Ratios | |||||
| Price/Earnings ttm | N/A | ||||